Better Living Showcase reposted this
In a move that underscores its global ambitions, Australian biotech Memphasys Reproductive Biotechnology (ASX: MEM) has signed a Letter of Intent (LOI) with Heranova Lifesciences HK Limited to bring the groundbreaking Felix™ System to the rapidly growing Greater China fertility market. The partnership not only expands Memphasys’ international footprint but also highlights the synergy between two companies committed to advancing women’s health. The Felix™ System is Memphasys’ proprietary sperm selection device designed to improve outcomes in assisted reproductive treatments. By combining electrophoresis with size-exclusion membranes, the system isolates the most viable sperm for fertilisation, providing a significant advantage over traditional methods. Currently in clinical trials across nine sites in Australia, the Felix™ System is nearing the completion of its recruitment phase. The data generated will underpin Memphasys’ CE marking application and support its introduction to fertility clinics worldwide. Heranova, founded in 2022, has swiftly established itself as a leader in women’s health innovation. With bicoastal operations in the United States, Heranova focuses on diagnostics and treatments for endometriosis, bacterial vaginosis, and fertility, addressing critical unmet needs in women’s healthcare. The company recently raised USD 13.5 million in seed and seed+ funding, backed by investors such as Pivotal Bioventure China, Sinovation Ventures (创新工场), Emerging Technology Partners, and Triwise Capital 勤智资本. The capital will fund the launch of non-invasive diagnostic tests for endometriosis and advance two novel therapeutic programs, one for bacterial vaginosis and another for non-hormonal treatment of endometriosis. Heranova’s world-class Scientific Advisory Board reflects its commitment to innovation in women’s health. Members include: - Joe Leigh Simpson, M.D., FACOG, FACMG, MD: President of the International Federation of Fertility Societies. - Denny Sakkas, PhD: Chief Scientific Officer at Boston IVF. - Toni Marengo, MD, FACOG, MD: Chief Medical Officer at Planned Parenthood of the Pacific Southwest. - Aleksandar Rajkovic, MD, PhD: Chief Genomic Officer at the University of California, San Francisco. - Willard Dere, MD: Professor Emeritus at the University of Utah School of Medicine. - Ronald F. Feinberg, MD PhD, MD, PhD: Chief Medical Officer and IVF Director at RADfertility and CCRM-Delaware. Read full article on TechInvest Magazine website here: https://lnkd.in/gnsa4-Su Lindley Edwards Ph.D David Ali PhD Michael Atkins Paul Wright Hassan Bakos PhD MBA John Aitken Chapter One Advisors Colin Jacoby Alex Baker Jedd Penkethman